Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Atomera Incorporated (ATOM) vs Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Price & Performance

Atomera IncorporatedTrade
Bio-Rad Laboratories, Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Atomera Incorporated vs Bio-Rad Laboratories, Inc. Class A Common Stock — how do they compare? Atomera Incorporated trades at $6.48 (market cap $241.98M), while Bio-Rad Laboratories, Inc. Class A Common Stock trades at $298.3 (market cap $8.02B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock is far larger — about 33.1× Atomera Incorporated's market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, Atomera Incorporated nearer its low. Which is the better fit depends on your goals.

ATOMBIO
Market Cap
$241.98M$8.02B
Sector
TechnologyHealth
52-Week High
$12.11$339.75
52-Week Low
$1.99$241.71
Enterprise Value
$202.19M$7.84B

Returns comparison

Trailing returns across standard periods

About Atomera Incorporated

Atomera is a semiconductor materials engineering company. Its Mears Silicon Technology (MST) is a patented thin film that enhances transistor performance, power efficiency, and cost for global chip manufacturers.

Read more on ATOM

About Bio-Rad Laboratories, Inc. Class A Common Stock

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Read more on BIO